Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Masimo CorporationNASDAQ: MASI
Financing Cash Flow · Q1 FY2026 · quarter ended Apr 2026
Financing cash flow grows, but more slowly than its trailing trend
Q1 FY2026 financing cash flow of $70.2M (cash outflow) rose 46.9% year over year, behind the +269.7% change in trailing-twelve-month financing cash flow. Sequentially, it fell 67.3% from the prior quarter.
Context
- Financing cash flow amounted to 34.1% of revenue in FY2025, up 28.1 pp from a year earlier.
- Financing cash flow increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +46.9% toward the trailing-twelve-month pace of +269.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (520.7M) USD
- Year-over-year change
- -314.6%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | (520.7M) | -314.6% |
| FY2024 | 2024-12-28 | (125.6M) | -120.0% |
| FY2023 | 2023-12-31 | (57.1M) | -111.0% |
| FY2022 | 2022-12-31 | 520.4M | +525.2% |
| FY2021 | 2021-12-31 | (122.4M) | — |
Financing Cash Flow vs competitors
How MASI compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +269.7% is the 3rd highest of 11, against a peer median of -53.4%.
- Financing cash flow amounts to 34.8% of revenue for MASI, versus a peer median of 2.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $588.5M USD | -40.8% | -14.2% | 9.0% | |
| LTM Apr 2026 | $543.1M USD | +269.7% | — | 34.8% | |
| FY2025 | €531.94M EUR | +1785.8% | +154.7% | — | |
| LTM Jun 2026 | $381M USD | +632.7% | -29.4% | 2.8% | |
| LTM Jun 2026 | $270M USD | -93.2% | +43.1% | 2.4% | |
| LTM Jun 2026 | $225.53M USD | -24.4% | -21.6% | 5.7% | |
| LTM Jun 2026 | $121.1M USD | -66.0% | — | 4.7% | |
| LTM Sep 2026 | $61M USD | +131.3% | -27.2% | 0.1% | |
| LTM Sep 2026 | $15.76M USD | -106.1% | +0.6% | 5.6% | |
| LTM Jun 2026 | $11.79M USD | -85.9% | +4.5% | 1.5% | |
| LTM Jun 2026 | €9.63M EUR | -88.1% | — | 0.8% | |
| Peer median (excluding MASI) | — | -53.4% | -6.8% | 2.8% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 229.6M | 143.5M | 81.5M | (304.9M) | (151.5M) |
| Depreciation & Amortization | 35.6M | 136.1M | 98.3M | 103M | 38.8M |
| Deferred Income Tax | (15.1M) | (39.3M) | (35.6M) | (38.2M) | 11.8M |
| Stock-Based Compensation | 44.7M | 47.7M | 7M | 41.5M | 35.8M |
| Change in Working Capital | (31.5M) | (261.8M) | (70.9M) | (10.7M) | (89.9M) |
| Accounts Receivables | (76.9M) | (151.3M) | 91.9M | (60.2M) | 17.2M |
| Inventory | 13.5M | (155.9M) | (69.2M) | (7.5M) | (112.1M) |
| Accounts Payables | 11M | 60.5M | (19.6M) | 14.8M | (27.1M) |
| Other Working Capital | 20.9M | (15.1M) | (74M) | 42.2M | 32.1M |
| Other Non-Cash Items | 1.3M | 3.2M | 13.8M | 405.7M | 372.2M |
| Operating Cash Flow | 264.6M | 29.4M | 94.1M | 196.4M | 217.2M |
| Capital Expenditures | (34.9M) | (56.3M) | (87.7M) | (51.1M) | (19.4M) |
| Acquisitions (Net) | 0 | (999.7M) | 7.5M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12M) | (5.2M) | (44.7M) | (31.2M) | 294.5M |
| Investing Cash Flow | (37.5M) | (1.06B) | (81.2M) | (51.2M) | 275.1M |
| Debt Repayment | 0 | 939.2M | (51.2M) | (146.8M) | (207.8M) |
| Common Stock Issued | 23.2M | 8.1M | 7M | 25.2M | 71.4M |
| Common Stock Repurchased | (128.9M) | (401.5M) | 0 | 0 | (363.7M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (16.7M) | (25.4M) | (12.9M) | (4M) | (20.6M) |
| Financing Cash Flow | (122.4M) | 520.4M | (57.1M) | (125.6M) | (520.7M) |
| Effect of Forex Changes | (1.3M) | (30.9M) | 2.8M | (6.4M) | 53.8M |
| Net Change in Cash | 103.4M | (538.8M) | (41.4M) | 13.2M | 26M |
| Free Cash Flow | 229.7M | (26.9M) | 6.4M | 145.3M | 197.8M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.